Retinoic acid-OVA

Retinoic acid-OVA is a conjugate of Retinoic acid (HY-14649) and Ovalbumin (OVA) . By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells[1].

Product Specifications

UNSPSC

12352100

Target

Biochemical Assay Reagents

Related Pathways

Others

Field of Research

Inflammation/Immunology

Smiles

[Retinoicacid-OVA]

References & Citations

[1]Wu L, et al. Retinoid X Receptor Agonists Upregulate Genes Responsible for the Biosynthesis of All-Trans-Retinoic Acid in Human Epidermis. PLoS One. 2016 Apr 14;11 (4) :e0153556.